First Bologna, then Poseidon: What are we still missing to personalize care for patients undergoing assisted reproductive technology with a poor prognosis?

Previous
Previous

Reproductive surgery: revisiting its origins and role in the modern management of fertility

Next
Next

Fine-tuning the dose of recombinant human follicle-stimulating hormone alfa to individualize treatment in ovulation induction and ovarian stimulation cycles: a real-world database analysis